Interactions between mouse IgG2 antibodies are common and mediated by plasma C1q

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 5, 2006, Pages 321-328

  Wood, Brent L ^a   Levin, Greg R ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Complement C1q; Interaction; Mouse IgG2 antibody

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; ARTIFACT; BLOOD; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; HEAT TREATMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR INTERACTION; MOUSE; PRIORITY JOURNAL;

ANIMALS; ARTIFACTS; COMPLEMENT C1Q; FLOW CYTOMETRY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MICE;

EID: 33749562083     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20138     Document Type: Article

References (16)

1. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: Unravelling the immune system. Nat Rev Immunol 2004:4:648-655.
2. Wood B. Multicolor immunophenotyping: Human immune system hematopoiesis. Methods Cell Biol 2004;75:559-576.
3. Ekong T, Gompels M, Clark C, Parkin J, Pinching A. Double-staining artefact observed in certain individuals during dual-colour immunophenotyping of lymphocytes by flow cytometry. Cytometry 1993; 14:679-684.
4. Nicholson JK, Rao PE, Calvelli T, Stetler-Stevenson M, Browning SW, Yeung L, Marti GE. Artifactual staining of monoclonal antibodies in two-color combinations is due to an immunoglobulin in the serum and plasma. Cytometry 1994;18:140-146.
5. Fryer JP, Leventhal JR, Pao W, Stadler C, Jones M, Walsh T, Zhong R, Zhang Z, Wang H, Goodman DJ, Kurek M, d'Apice AJ, Blondin B, Ivancic D, Buckingham F, Kaufman D, Abecassis M, Stuart F, Anderson BE. Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival. Transplantation 2000; 70:828-836.
6. Lamvik J, Hella H, Liabakk NB, Halaas O. Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigens. Cytometry 2001;45:187-193.
7. Andersen DC, Koch C, Jensen CH, Skjodt K, Brandt J, Teisner B. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 2004;25:17-30.
8. Papoian R. Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA). J Immunoassay 1992;13:289-296.
9. Primus FJ, Kelley EA, Hansen HJ, Goldenberg DM. "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988;34:261-264.
10. Duncan AR, Winter G. The binding site for C1q on IgG. Nature 1988;332:738-740.
11. Kishore U, Reid KB. C1q: Structure, function, and receptors. Immunopharmacology 2000;49:159-170.
12. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol 2000;164:4178-4184.
13. Koolwijk P, Boot JH, Griep R, Bast BJ. Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies. Mol Immunol 1991;28:567-576.
14. Leatherbarrow RJ, Dwek RA. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: A novel C1q binding assay. Mol Immunol 1984;21321-327.
15. Seino J, Eveleigh P, Warnaar S, van Haarlem LJ, van Es LA, Daha MR. Activation of human complement by mouse and mouse/human chimeric monoclonal antibodies. Clin Exp Immunol 1993;94:291-296.
16. Roos A, Nauta AJ, Broers D, Faber-Krol MC, Trouw LA, Drijfhout JW, Daha MR. Specific inhibition of the classical complement pathway by C1q-binding peptides. J Immunol 2001;167:7052-7059.